Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/301277 stock hub

SHE/301277 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/301277is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.4B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/301277

In the news

Latest news · SHE/301277

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E43.9

P25 23.5P50 41.3P75 83.2

ROE6.2

P25 -0.9P50 4.1P75 8.8

ROIC10.1

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/301277 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

212

Groups with data

Currency

CNY

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	981
Employees Change	-61%
Employees Change Percent	-5.85
Enterprise value	CNY 3.8B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE1000065K2
Last refreshed	2026-05-10
Market cap	CNY 4.4B
Price	CNY 11.32
Price currency	CNY
Rev Per Employee	672,310.89x
Sector	Healthcare
Sic	2834
Symbol	she/301277
Website	https://www.newlandpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.27%
EV Earnings	37.44x
EV/EBIT	38.09x
EV/EBITDA	23.82x
EV/FCF	-1,324.09x
EV/Sales	5.72x
FCF yield	-0.06%
P/B ratio	2.8x
P/E ratio	43.93x
P/S ratio	6.73x
PE Ratio3 Y	29.97x
PE Ratio5 Y	29.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.07%
EBITDA Margin	23.69%
Gross margin	30.9%
Gross Profit	CNY 203.8M
Gross Profit Growth	-31.01%
Gross Profit Growth Q	-24.61%
Gross Profit Growth3 Y	-4.39%
Gross Profit Growth5 Y	24.04%
Net Income	CNY 100.8M
Net Income Growth	-42.18%
Net Income Growth Q	-36.19%
Net Income Growth3 Y	-11.41%
Net Income Growth5 Y	28.65%
Pretax Margin	16.84%
Profit Margin	15.28%
Profit Per Employee	CNY 102,729
ROA	3.39
Roa5y	7.95
ROCE	6.03
ROE	6.23
Roe5y	15.47
ROIC	10.1
Roic5y	22.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-5.35%
Cagr3y	2.42%
EPS Growth	-41.63
EPS Growth Q	-35.55
EPS Growth3 Y	-16.51
EPS Growth5 Y	21.27
OCF Growth	-54.57%
OCF Growth3 Y	-22.52%
Revenue Growth	-13.41x
Revenue Growth Q	-5.84x
Revenue Growth3 Y	1.04x
Revenue Growth5 Y	17.45x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.36
Assets	CNY 1.8B
Cash	CNY 666.2M
Current Assets	CNY 1.1B
Current Liabilities	CNY 174.1M
Debt	CNY 1.9M
Debt EBITDA	CNY 0.01
Debt Equity	CNY 0
Debt FCF	CNY -0.65
Equity	CNY 1.6B
Interest Coverage	868.9
Liabilities	CNY 236.1M
Long Term Assets	CNY 716.8M
Long Term Liabilities	CNY 62M
Net Cash	CNY 664.4M
Net Cash By Market Cap	CNY 14.97
Net Cash Growth	-15.1%
Net Debt EBITDA	CNY -4.25
Net Debt Equity	CNY -0.42
Tangible Book Value	CNY 1.5B
Tangible Book Value Per Share	CNY 3.92
WACC	5.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.35
Inventory Turnover	9.33
Net Working Capital	CNY 265.9M
Quick ratio	5.95
Working Capital	CNY 931.7M
Working Capital Turnover	CNY 0.7

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.94%
Dividend Growth	-50%
Dividend Growth Years	3%
Dividend per share	CNY 0.2
Dividend Years	4
Dividend Yield	1.77%
Ex Div Date	2026-04-30
Last Dividend	CNY 0.2
Payout Frequency	Annual
Payout Ratio	111.16%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-5.34%
200-day SMA	13.01
3Y total return	7.44%
50-day SMA	11.97
50-day SMA vs 200-day SMA	50under200
All Time High	18.38
All Time High Change	-38.41%
All Time High Date	2025-06-03
All Time Low	6.64
All Time Low Change	70.4%
All Time Low Date	2024-02-06
ATR	0.3
Beta	0.32
Beta1y	0.28
Beta2y	0.44
Ch YTD	-3.99
High	11.43
High52	18.38
High52 Date	2025-06-03
High52ch	-38.41%
Low	11.31
Low52	10.8
Low52 Date	2026-03-23
Low52ch	4.82%
Ma50ch	-5.45%
Price vs 200-day SMA	-12.99%
RSI	38.77
RSI Monthly	46.12
RSI Weekly	37.04
Sharpe ratio	0.03x
Sortino ratio	0.2
Total Return	2.7%
Tr YTD	-2.29
Tr1m	-5.81%
Tr1w	-1.82%
Tr3m	-9.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 99.4M
Operating Income Growth	-46.82
Operating Income Growth Q	-29.52
Operating Income Growth3 Y	-13.35
Operating Income Growth5 Y	29.87
Operating margin	15.07

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	98,876,400%
Net Borrowing	-1,798,258
Shares Insiders	63.76%
Shares Institutions	0.39%
Shares Out	392,078,400
Shares Qo Q	0.95%
Shares Yo Y	-0.94%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY -2.8M
Average Volume	2,857,368.4x
Bv Per Share	4.05
CAPEX	CNY -63.8M
Ch1m	-7.44
Ch1w	-1.82
Ch1y	-6.98
Ch3m	-11.29
Ch3y	-0.21
Ch6m	-12.25
Change	0%
Change From Open	-0.09
Close	11.32
Days Gap	0.09
Depreciation Amortization	56,862,842
Dollar Volume	35,311,347.6
Earnings Date	2026-04-24
EBIT	CNY 99.4M
EBITDA	CNY 156.2M
EPS	CNY 0.26
F Score	4
FCF	CNY -2.8M
FCF EV Yield	-0.08x
FCF Per Share	CNY -0.01
Financing CF	-113,010,524
Fiscal Year End	December
Founded	2,005
Graham Number	4.84513
Graham Upside	-57.2
Income Tax	CNY 11.8M
Investing CF	-157,996,314
Is Primary Listing	1
Last Earnings Date	2026-04-24
Last Report Date	2026-03-31
Last Split Date	2025-04-16
Last Split Type	Forward
Lynch Fair Value	CNY 6.44
Lynch Upside	-43.09
Ma150	12.45
Ma150ch	-9.05%
Ma20	11.74
Ma20ch	-3.57%
Net CF	-210,089,151
Next Earnings Date	2026-08-12
Open	11.33
P OCF Ratio	72.86
Payment Date	2026-04-30
Position In Range	8.33
Ppne	648,079,268
Price Date	2026-05-08
Price EBITDA	CNY 28.41
Ptbv Ratio	2.89
Relative Volume	1.09x
Revenue	659,536,983x
Tax By Revenue	1.78x
Tax Rate	10.59%
Tr6m	-10.7%
Volume	3,119,377

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/301277 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.8%

$0.20 annual per share

Payout ratio

+111.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

3 consecutive years of growth

Total shareholder yield

+2.7%

Next ex-dividend date: 2026-04-30

Performance

SHE/301277 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/301277?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.4%

Share of float held by funds and institutions

Insider ownership

+63.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.9%

Negative means the company is buying back shares.

Technical

SHE/301277 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.8

Neutral momentum band

Price vs 200-day MA

-13.0%

50/200-day relationship not available

Beta (5Y)

0.32

Less volatile than the market

Sharpe ratio

0.03

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/301277

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/301277 stock rating?

she/301277 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/301277 analysis?

The full report lives at /stocks/she/301277/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/301277?

The latest report frames she/301277 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/301277 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.